⌘K

Login Start Free

Home/Filings/4/0001104659-22-069381

4//SEC Filing

Truong Vu 4

Accession 0001104659-22-069381

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:11 PM ET

Size

5.2 KB

Accession

0001104659-22-069381

Insider Transaction Report

Form 4

Period: 2022-06-07

Aridis Pharmaceuticals, Inc.ARDS

DirectorCEO, CSO, Director10% Owner

Transactions

Award
Stock Options
2022-06-07+88,360→ 687,750 total
Exercise: $1.06Exp: 2032-06-07→ Common Stock (88,360 underlying)

Footnotes (1)

[F1]The stock options vest in equal installments over 12 months, beginning on June 7, 2022.

Documents

1 file

4
tm2217955-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1

filerCIK 0001749993

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 5:11 PM ET
Size: 5.2 KB

View on SEC.gov